IL-27 increases BST-2 expression in human monocytes and T cells independently of type i IFN

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Guzzo, Christina ^a   Jung, Masany ^a   Graveline, Ashley ^a   Banfield, Bruce W ^a   Gee, Katrina ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOBEC3 PROTEIN, HUMAN; BST2 PROTEIN, HUMAN; CYTOSINE DEAMINASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; INTERFERON; INTERLEUKIN 17; LEUKOCYTE ANTIGEN; MESSENGER RNA;

ARTICLE; CELL LINE; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; MONOCYTE; PHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGENS, CD; CELL LINE; CYTOSINE DEAMINASE; FLOW CYTOMETRY; GPI-LINKED PROTEINS; HUMANS; INTERFERON TYPE I; INTERLEUKIN-17; MONOCYTES; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84871815459     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00974     Document Type: Article

References (34)

1. Larousserie, F. et al. Differential effects of IL-27 on human B cell subsets. J. Immunol. 176(10), 5890-5897 (2006).
2. Lucas, S. et al. IL-27 regulates IL-12 responsiveness of naive CD41T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U. S. A. 100(25), 15047-15052 (2003). (Pubitemid 37518014)
3. Pflanz, S. et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(1) T cells. Immunity. 16(6), 779-790 (2002). (Pubitemid 34786477)
4. Imamichi, T. et al. IL-27, a novel anti-HIV cytokine, activates multiple interferoninducible genes in macrophages. AIDS 22(1), 39-45 (2008). (Pubitemid 350294876)
5. Greenwell-Wild, T. et al. Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood. 114(9), 1864-1874 (2009).
6. Blasius, A. L. et al. Bonemarrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177(5), 3260-3265 (2006). (Pubitemid 44277845)
7. Stetson, D. B. & Medzhitov, R. Type I interferons in host defense. Immunity. 25(3), 373-381 (2006). (Pubitemid 44354218)
8. Tokarev, A. et al. Antiviral activity of the interferon-induced cellular protein BST- 2/tetherin. AIDS Res. Hum. Retroviruses. 25(12), 1197-1210 (2009).
9. Neil, S. J., Zang, T. & Bieniasz, P. D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 451(7177), 425-430 (2008). (Pubitemid 351158893)
10. Van, Damme, N. et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host. Microbe. 3(4), 245-252 (2008). (Pubitemid 351494713)
11. Jouvenet, N. et al. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83(4), 1837-1844 (2009).
12. Kaletsky, R. L. et al. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 106(8), 2886-2891 (2009).
13. Sakuma, T. et al. Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 83(5), 2382-2385 (2009).
14. Radoshitzky, S. R. et al. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J. Virol. 84(20), 10569-10580 (2010).
15. Mansouri, M. et al. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 83(19), 9672-9681 (2009).
16. Weidner, J. M. et al. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 84(24), 12646-12657 (2010).
17. Kupzig, S. et al. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic. 4(10), 694-709 (2003). (Pubitemid 37168591)
18. Erikson, E. et al. In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans. Proc. Natl. Acad. Sci. U. S. A. 108(33), 13688-13693 (2011).
19. Homann, S. et al. Upregulation of BST-2/Tetherin by HIV infection in vivo. J. Virol. 85(20), 10659-10668 (2011).
20. Miyagi, E. et al. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U. S. A. 106(8), 2868-2873 (2009).
21. Bego, M. G., Mercier, J. & Cohen, E. A. Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling. J. Virol. 86(7), 3513-3527 (2012).
22. Ohtomo, T. et al. Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem. Biophys. Res. Commun. 258(3), 583-591 (1999). (Pubitemid 29290312)
23. Matsuda, A. et al. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene. 22(21), 3307-3318 (2003). (Pubitemid 36712943)
24. Guzzo, C. et al. IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes. J. Immunol. 188(2), 864-873 (2012).
25. Guzzo, C., Che Mat, N. F. & Gee, K. Interleukin-27 induces a STAT1/3 and NFkappaB dependent proinflammatory cytokine profile in human monocytes. J. Biol. Chem. 285(32), 24404-24411 (2010).
26. Guzzo, C. et al. Impact of HIV infection, highly active antiretroviral therapy, and hepatitis C coinfection on serum interleukin-27. AIDS. 24(9), 1371-1374 (2010).
27. Pflanz, S. et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172(4), 2225-2231 (2004). (Pubitemid 38182370)
28. Symons, J. A., Alcami, A. & Smith, G. L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell. 81(4), 551-560 (1995).
29. Kawa, S. et al. Construction of a conventional non-radioisotope method to quantify HM1.24 antigens: correlation of HM1.24 levels and ADCC activity of the humanized antibody against HM1.24. Leuk. Res. 30(8), 949-956 (2006).
30. Kanda, N. &Watanabe, S. IL-12, IL-23, and IL-27 enhance human beta-defensin- 2 production in human keratinocytes. Eur. J. Immunol. 38(5), 1287-1296 (2008).
31. He, L. et al. Upregulation of interleukin-27 expression is correlated with higher CD41 T cell counts in treatment of naive human immunodeficiency virusinfected Chinese. 3(1), 6-10 (2011).
32. Jones, P. H. et al. Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivo. Retrovirology. 9: 10, 10 (2012).
33. Dube, M. et al. Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J. Virol. 83(9), 4574-4590 (2009).
34. Liberatore, R. A. & Bieniasz, P. D. Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 108(44), 18097-18101 (2011).